The Cooper Companies/$COO
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About The Cooper Companies
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Ticker
$COO
Sector
Primary listing
Employees
16,000
Headquarters
Website
COO Metrics
BasicAdvanced
$14B
34.67
$2.04
1.02
-
Price and volume
Market cap
$14B
Beta
1.02
52-week high
$103.34
52-week low
$61.78
Average daily volume
2.4M
Financial strength
Current ratio
2.116
Quick ratio
0.908
Long term debt to equity
29.108
Total debt to equity
29.67
Interest coverage (TTM)
7.24%
Profitability
EBITDA (TTM)
1,127.7
Gross margin (TTM)
66.96%
Net profit margin (TTM)
10.08%
Operating margin (TTM)
18.37%
Effective tax rate (TTM)
34.04%
Revenue per employee (TTM)
$250,000
Management effectiveness
Return on assets (TTM)
3.87%
Return on equity (TTM)
5.01%
Valuation
Price to earnings (TTM)
34.669
Price to revenue (TTM)
3.481
Price to book
1.69
Price to tangible book (TTM)
4.92
Price to free cash flow (TTM)
34.253
Free cash flow yield (TTM)
2.92%
Free cash flow per share (TTM)
2.065
Growth
Revenue change (TTM)
6.35%
Earnings per share change (TTM)
13.47%
3-year revenue growth (CAGR)
7.91%
10-year revenue growth (CAGR)
8.38%
3-year earnings per share growth (CAGR)
-2.08%
10-year earnings per share growth (CAGR)
7.35%
What the Analysts think about COO
Analyst ratings (Buy, Hold, Sell) for The Cooper Companies stock.
Bulls say / Bears say
Non-GAAP diluted EPS of $1.10 in Q3 2025 beat the $1.07 consensus, underscoring operational efficiency and margin strength. (Reuters)
Fiscal Q3 revenue rose 6% year-over-year to $1.06 billion, driven by robust performances in CooperVision and CooperSurgical segments. (Reuters)
The company raised its full-year adjusted EPS outlook to $4.08–$4.12, reflecting confidence in earnings growth and cash flow generation. (Reuters)
Lowered its fiscal 2025 revenue forecast to $4.07–$4.10 billion from $4.11–$4.15 billion due to softer demand in Asia Pacific and North America, sending shares down nearly 10%. (Reuters)
CooperVision segment sales of $718.4 million in Q3 missed consensus of $721.8 million, highlighting execution risks in its core contact lens business. (Reuters)
Anticipates a $24 million headwind from U.S. tariffs by the end of fiscal 2026, introducing additional margin pressure. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 10 Nov 2025.
COO Financial Performance
Revenues and expenses
COO Earnings Performance
Company profitability
COO News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for The Cooper Companies stock?
The Cooper Companies (COO) has a market cap of $14B as of November 11, 2025.
What is the P/E ratio for The Cooper Companies stock?
The price to earnings (P/E) ratio for The Cooper Companies (COO) stock is 34.67 as of November 11, 2025.
Does The Cooper Companies stock pay dividends?
No, The Cooper Companies (COO) stock does not pay dividends to its shareholders as of November 11, 2025.
When is the next The Cooper Companies dividend payment date?
The Cooper Companies (COO) stock does not pay dividends to its shareholders.
What is the beta indicator for The Cooper Companies?
The Cooper Companies (COO) has a beta rating of 1.02. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.